VVT Medical Inc.

Varicose vein treatment in 1,000+ clinics

Logo of YYT Medical featuring stylized check mark and bold text.

VVT Technologies Inc. (TSXV:VVTM)

  • Develops, manufactures, and distributes minimally invasive, non-thermal, non-tumescent (NT-NT) solutions for the treatment of vein diseases, starting with varicose veins

  • FDA-cleared and CE-marked

  • Enables safe, office-based procedures with no anesthesia, no downtime, and minimal pain and side effects

  • 1,000 clinics in the USA, India, Europe and Korea

Key Stats:

  • Located: Kfar Saba, Israel

  • Founded: 2007

  • Employees: Approximately 10–50

  • Website: www.vvtmed.com

  • Contact: +972-9-766-0480 | info@vvtmed.com

  • Corporate Presentation: Click Here

VVTM stock price by TradingView
VVTM fundamentals by TradingView
A medical illustration showing a healthcare professional injecting a syringe into a blood vessel with red blood cells and white blood cells inside.
Medical syringe and IV tubing labeled ScleroSafe™ on a light background.
Packaging for VVT Medical ScleroSafe peripheral venous aspiration and infusion kit. The box features a visual of the kit components, including a syringe and catheter, with branding and product details such as 150mm size.

VVT’s Team

  • Professional man in a black suit and tie smiling in an office setting with large windows

    Erez Tetro

    Chief Executive Officer, Director

  • Portrait of a smiling woman with short gray hair, wearing glasses and a navy blazer, crossing her arms against a light gray background.

    Orly Efraty

    Vice President of Global Marketing

  • A woman with shoulder-length brown hair wearing a blue headband with a flower, a light blue blouse, and a subtle smile, posed against a light gray background.

    Liron Tayeb

    R&D Director

Person in white lab coat and hairnet using a microscope in a laboratory setting.
VVT Med Inc. Engages Independent Trading Group as Market Maker
Jeff Maser Jeff Maser

VVT Med Inc. Engages Independent Trading Group as Market Maker

TORONTO, Aug. 13, 2025 /CNW/ - VVT Med Inc. (TSXV: VVTM) ("VVT" or the "Company"), announces that it has entered into a market making service agreement (the "Agreement") with Independent Trading Group ("ITG") dated August 13, 2025. Pursuant to the Agreement, ITG will provide market-making services in accordance with TSX Venture Exchange (the "TSVX") policies and will trade shares of the Company on the TSXV and all other trading venues with the objective of maintaining a reasonable market and improving the liquidity of the Company's common shares.

Read More